PDC-1421 not checked

BioLite, Inc. · BLI-1005

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
4 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“PDC-1421 Capsule is a botanical investigational new drug containing the extract of Radix Polygalae (Polygala tenuifolia Willd.) as active ingredient.”In the company’s words, NCT03833206 on ClinicalTrials.gov
Tested for
Major Depressive Disorder
Main trialPhase 1/2
“The purpose of this study is to evaluate the safety and the effective doses of PDC-1421 in cancer patients with depression.”In the company’s words, NCT03833206 on ClinicalTrials.gov
Other names
Extract of Radix Polygalae · BLI-1005

Other drugs for Major Depressive Disorder

All 36 drugs for Major Depressive Disorder

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 1/2Not yet recruiting 28 Feb 2028 A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
Phase 2Completed 12 Mar 2019 A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
Phase 2Completed 15 Jul 2020 A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)
Phase 2Completed 6 Dec 2023 PDC-1421 Treatment in Adult Patients With ADHD
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow PDC-1421

Following is part of Solo: you see every change to PDC-1421 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in